Indian Government Mulls ban on Export of 12 Essential DrugsTop Stories

February 17, 2020 15:51
Indian Government Mulls ban on Export of 12 Essential Drugs

(Image source from: pristyncare.com)

The government of India is exploring measures in order to ensure that there would be no shortage of the essential drugs in India regarding treating the people with the coronavirus outbreak that has started in the city of Wuihan in the China’s Hubei’s province. The medicines are said to include mainly antibiotics, vitamins and hormones and therefore the government of India is said to witness the restriction on several medicines.

The expert committee that has been constituted by the government comprises of eight members. The committee has been formed in order to assess the availability of medicines in the country and has also suggested and has also suggested imposing the export restrictions on the twelve drugs which which include the antibiotics like chloramphenicol, neomycin, metronidazole, azythromicin, clindamycin, vitamins B1, B2 and B6 and also the hormones like progesterone that will be made used during the pregnant and in the problems that are related to the menstrual cycle.

The panel has also urged the Center to ask the states for invoking the provisions of the Essential Commodities Act and has also launched a strong vigil against the hoarders and also regarding any kind of the artificial shortage.

The official has added saying that he was also in touch with the Indian consulate general in Shanghai and has also receive the information that the API producing units in all the other provinces had resumed the production and therefore 45-50 per cent made from China are said to be secured.

Around 80-85 percent of the APIs are being imported to India from China where as few major pharma companies which include like Lupin, Sun Pharma and Dr Reddy’s Laboratories would manufacture the APIs locally for few medicines but is used mostly for captive use.

The data has been sought by the committee from the leading pharmaceutical firms that are leading, industry associations like Indian Drug Manufacturers Association(IDMA), Indian Pharmaceutical Alliance (IPA) and Organization of Pharmaceutical Products of India (OPPI).

The chemists have also been consulted and the druggists associations in order to get a feedback on the stocks that are present in the market.

By Shrithika Kushangi

If you enjoyed this Post, Sign up for Newsletter

(And get daily dose of political, entertainment news straight to your inbox)

Rate This Article
(0 votes)
Tagged Under :
coronavirus  drugs